Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (101-110 of 283) with videos related to

Pageof 29
Sort By:
Future Oncology (London, England)|May 8, 2013
ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinomaNicholas J Giacalone, Robert B Den, Rosana Eisenberg, et al.
Psychosomatic Medicine|October 11, 2021
Psychological Symptom Trajectories and Non-Small Cell Lung Cancer Survival: A Joint Model AnalysisBarbara L Andersen, Joseph P McElroy, David P Carbone, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cellsYunguang Sun, Siyuan Zheng, Artour Torossian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2011
The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation statusMasanori Ii, Hua Li, Yasushi Adachi, et al.
BMC Cancer|April 17, 2019
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysisAdrian D Vickers, Katherine B Winfree, Gebra Cuyun Carter, et al.
Lung Cancer (Amsterdam, Netherlands)|June 8, 2020
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung CancerMichael F Sharpnack, Ju Hwan Cho, Travis S Johnson, et al.
Journal of Cancer Metastasis and Treatment|November 15, 2021
RANBP9 as potential therapeutic target in non-small cell lung cancerAnna Tessari, Shimaa H A Soliman, Arturo Orlacchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 3, 2026
Dietary and Lifestyle Patterns Among Young Patients with Lung Cancer: Analysis of Mutation-Specific PhenotypesSarah Diana Gorbatov, Marisa A Bittoni, Anna H Wu, et al.
Clinical Lung Cancer|January 8, 2021
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele FrequencyJean G Bustamante Alvarez, Sarah Janse, Dwight H Owen, et al.
Pageof 29

Showing results (101-110 of 283) with videos related to

Sort By:
Pageof 29
Future Oncology (London, England)|May 8, 2013
ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinomaNicholas J Giacalone, Robert B Den, Rosana Eisenberg, et al.
Psychosomatic Medicine|October 11, 2021
Psychological Symptom Trajectories and Non-Small Cell Lung Cancer Survival: A Joint Model AnalysisBarbara L Andersen, Joseph P McElroy, David P Carbone, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cellsYunguang Sun, Siyuan Zheng, Artour Torossian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2011
The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation statusMasanori Ii, Hua Li, Yasushi Adachi, et al.
BMC Cancer|April 17, 2019
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysisAdrian D Vickers, Katherine B Winfree, Gebra Cuyun Carter, et al.
Lung Cancer (Amsterdam, Netherlands)|June 8, 2020
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung CancerMichael F Sharpnack, Ju Hwan Cho, Travis S Johnson, et al.
Journal of Cancer Metastasis and Treatment|November 15, 2021
RANBP9 as potential therapeutic target in non-small cell lung cancerAnna Tessari, Shimaa H A Soliman, Arturo Orlacchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 3, 2026
Dietary and Lifestyle Patterns Among Young Patients with Lung Cancer: Analysis of Mutation-Specific PhenotypesSarah Diana Gorbatov, Marisa A Bittoni, Anna H Wu, et al.
Clinical Lung Cancer|January 8, 2021
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele FrequencyJean G Bustamante Alvarez, Sarah Janse, Dwight H Owen, et al.
Pageof 29